Korean J Obstet Gynecol.  2006 Jun;49(6):1212-1218.

Minimal invasive treatment of uterine myoma: Laparoscopic radiofrequency myolysis

Affiliations
  • 1Department of Obstetrics and Gynecology, College of Medicine, Soonchunhyang University, Seoul, Korea. jjlee@hosp.sch.ac.kr

Abstract


OBJECTIVE
To evaluate the feasibility, efficacy and safety of minimal invasive treatment of uterine myoma with laparoscopic radiofrequency (RF) myolysis.
METHODS
69 patients with symptomatic uterine myomas underwent laparoscopy assisted RF myolysis. The accurate targeting and thermal intensity during the procedure were guided by trans-vaginal ultrasound. The measurement of myoma volume and UFS-QOL (Uterine fibroid symptom-quality of life) were obtained once at preoperative period and four times at postoperative period of one week, 1, 3, 6 months. Wilcoxon signed rank test (SPSS 7.5) was used to compare the volume changes of myoma. A significant level of p<0.05 was considered.
RESULTS
107 fibroids were treated with RF myolysis. The mean duration of RF procedure was 15.2+/-18.5 minutes. Mean preoperative volume of treated fibroids was 75.7 cm3 (range: 8.2-367.7) and the mean volume decrease was 12.1+/-10.2%, 32.3+/-40.2%, 48.3+/-33.6%, 53.5+/-18.1% at one week, 1, 3, 6 months. Fifty eight patients had improved symptom severity with UFS-QOL score: symptom severity score 30.8+/-8.2 (mean+/-S.D.), quality of life score 20.3+/-9.2 after RF myolysis. There were 3 cases of RF heat related complication.
CONCLUSION
Early experience of laparoscopy assisted RF myolysis in the treatment of uterine fibroids shows that the method is safe and effective under the guidance of trans-vaginal sonification.

Keyword

Radiofrequency; Myolysis; Myoma uteri

MeSH Terms

Hot Temperature
Humans
Laparoscopy
Leiomyoma*
Myoma
Postoperative Period
Preoperative Period
Quality of Life
Ultrasonography
Full Text Links
  • KJOG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr